Literature DB >> 8344937

Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.

S K Moestrup1, S Nielsen, P Andreasen, K E Jørgensen, A Nykjaer, H Røigaard, J Gliemann, E I Christensen.   

Abstract

Epithelial glycoprotein 330 (gp330) is structurally similar to the multifunctional alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP), gp330 and alpha 2MR/LRP bind Ca2+ with high affinity, and both receptors bind and mediate endocytosis of alpha 2MR-associated protein (RAP). In the present report, we describe that affinity-purified gp330 from rabbit renal cortex binds plasminogen activator inhibitor type-1 (PAI-1) complexed with urokinase-type plasminogen activator (uPA). alpha 2M-methylamine, which binds with high affinity to alpha 2MR/LRP, did not bind to gp330. The apparent Kd for binding of uPA.PAI-1 complexes was about 0.8 nM at 4 degrees C. The binding was calcium-dependent and inhibited by recombinant RAP (rRAP) and tissue type plasminogen activator-PAI-1 complexes. Thin sections of rabbit renal proximal tubules bound 125I-labeled uPA.PAI-1 and rRAP in the apical part of proximal tubules corresponding to the localization of gp330. The binding of 125I-uPA.PAI-1 complexes in tubules was abolished by excess unlabeled rRAP, and a rRAP-inhibitable endocytosis and degradation of labeled uPA.PAI-1 complexes was demonstrated by perfusion of isolated rabbit proximal tubules. The results establish an endocytotic function of gp330 and suggest that gp330 is an important component of the fibrinolytic system in gp330-containing epithelial as found in, for example, kidney and lung.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344937

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4.

Authors:  Angela Jen; Celia J Parkyn; Roy C Mootoosamy; Melanie J Ford; Alice Warley; Qiang Liu; Guojun Bu; Ilia V Baskakov; Søren Moestrup; Lindsay McGuinness; Nigel Emptage; Roger J Morris
Journal:  J Cell Sci       Date:  2010-01-15       Impact factor: 5.285

2.  Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

Authors:  B V Zlokovic; C L Martel; E Matsubara; J G McComb; G Zheng; R T McCluskey; B Frangione; J Ghiso
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 3.  Molecular analysis of the pathological autoimmune antigens of Heymann nephritis.

Authors:  M G Farquhar
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  Megalin-deficiency causes high myopia, retinal pigment epithelium-macromelanosomes and abnormal development of the ciliary body in mice.

Authors:  Tina Storm; Steffen Heegaard; Erik I Christensen; Rikke Nielsen
Journal:  Cell Tissue Res       Date:  2014-07-01       Impact factor: 5.249

5.  Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3).

Authors:  A Nykjaer; J C Fyfe; R Kozyraki; J R Leheste; C Jacobsen; M S Nielsen; P J Verroust; M Aminoff; A de la Chapelle; S K Moestrup; R Ray; J Gliemann; T E Willnow; E I Christensen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes.

Authors:  R P Czekay; R A Orlando; L Woodward; M Lundstrom; M G Farquhar
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

7.  beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.

Authors:  S K Moestrup; I Schousboe; C Jacobsen; J R Leheste; E I Christensen; T E Willnow
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

Authors:  S K Moestrup; S Cui; H Vorum; C Bregengård; S E Bjørn; K Norris; J Gliemann; E I Christensen
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.

Authors:  I Warshawsky; G Bu; A Mast; J E Saffitz; G J Broze; A L Schwartz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells.

Authors:  F Vilhardt; M Nielsen; K Sandvig; B van Deurs
Journal:  Mol Biol Cell       Date:  1999-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.